Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 27, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012982.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122563400, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122563400, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122563400, transcript variant X2
uncharacterized LOC122563400, transcript variant X5
uncharacterized LOC122563400, transcript variant X6
uncharacterized LOC122563400, transcript variant X4
proto-oncogene tyrosine-protein kinase LCK-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 102 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase LCK-like, transcript variant X2
proto-oncogene tyrosine-protein kinase LCK-like
family with sequence similarity 167 member B
myotubularin-related protein 9-like, transcript variant X1
myotubularin-related protein 9-like, transcript variant X2
myotubularin-related protein 9-like isoform X1
myotubularin-related protein 9-like isoform X2
myotubularin-related protein 9-like, transcript variant X3
myotubularin-related protein 9-like isoform X3
eukaryotic translation initiation factor 3, subunit I
eukaryotic translation initiation factor 3 subunit I
doublecortin domain-containing protein 2B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
doublecortin domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 124 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122563404, transcript variant X1
uncharacterized LOC122563404, transcript variant X2
zinc finger and BTB domain containing 8 opposite strand
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/arginine-rich splicing factor 10-like, transcript variant X2
serine/arginine-rich splicing factor 10-like, transcript variant X1
serine/arginine-rich splicing factor 10-like isoform X2
serine/arginine-rich splicing factor 10-like isoform X1
uncharacterized LOC122563464, transcript variant X1
uncharacterized protein LOC122563464 isoform X1
uncharacterized LOC122563464, transcript variant X2
uncharacterized protein LOC122563464 isoform X2
fatty acid binding protein 10a, liver basic
fatty acid-binding protein 10-A, liver basic
interleukin-22 receptor subunit alpha-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
interferon lambda receptor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
interferon lambda receptor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
interferon lambda receptor 1-like isoform X1
interferon lambda receptor 1-like isoform X2
digestive cysteine proteinase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
digestive cysteine proteinase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
digestive cysteine proteinase 1-like isoform X2
digestive cysteine proteinase 1-like isoform X1
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X5
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X7
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X6
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X8
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X3
proto-oncogene tyrosine-protein kinase Yrk-like isoform X3
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X4
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X11
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X10
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X9
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X1
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X2
proto-oncogene tyrosine-protein kinase Yrk-like, transcript variant X12
proto-oncogene tyrosine-protein kinase Yrk-like isoform X1
proto-oncogene tyrosine-protein kinase Yrk-like isoform X2
tyrosine-protein kinase Fyn-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase Yrk-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AT hook, DNA binding motif, containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
AT-hook DNA-binding motif-containing protein 1
adenosylmethionine decarboxylase 1, transcript variant X2
adenosylmethionine decarboxylase 1, transcript variant X1
S-adenosylmethionine decarboxylase proenzyme isoform X2
S-adenosylmethionine decarboxylase proenzyme isoform X1
wiskott-Aldrich syndrome protein family member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
CD164 sialomucin-like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CD164 sialomucin-like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
CD164 sialomucin-like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CD164 sialomucin-like 2 protein isoform X1
CD164 sialomucin-like 2 protein isoform X2
mediator of RNA polymerase II transcription, subunit 18 homolog (yeast), transcript variant X2
mediator of RNA polymerase II transcription, subunit 18 homolog (yeast), transcript variant X1
mediator of RNA polymerase II transcription subunit 18
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
polycomb protein SCMH1-like, transcript variant X2
polycomb protein SCMH1-like, transcript variant X1
polycomb protein SCMH1-like, transcript variant X5
polycomb protein SCMH1-like, transcript variant X4
polycomb protein SCMH1-like, transcript variant X3
polycomb protein SCMH1-like, transcript variant X7
polycomb protein SCMH1-like, transcript variant X6
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
schlafen-like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
schlafen-like protein 1, transcript variant X1
schlafen-like protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4b
COORDINATES: nucleotide motif:Rfam:12.0:RF00608
small nucleolar RNA SNORA16B/SNORA16A family
COORDINATES: nucleotide motif:Rfam:12.0:RF00190
synapse-associated protein 1-like, transcript variant X1
synapse-associated protein 1-like, transcript variant X2
synapse-associated protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
synapse-associated protein 1-like isoform X1
synapse-associated protein 1-like isoform X2
synapse-associated protein 1-like isoform X3
synapse-associated protein 1-like, transcript variant X4
synapse-associated protein 1-like isoform X4
synapse-associated protein 1-like, transcript variant X5
synapse-associated protein 1-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X5
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X4
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X1
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X2
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X3
transcription initiation factor TFIID subunit 12 isoform X2
transcription initiation factor TFIID subunit 12 isoform X1
transcription initiation factor TFIID subunit 12 isoform X3
discoidin, CUB and LCCL domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription cofactor vestigial-like protein 2, transcript variant X2
transcription cofactor vestigial-like protein 2, transcript variant X1
transcription cofactor vestigial-like protein 2, transcript variant X3
transcription cofactor vestigial-like protein 2, transcript variant X5
transcription cofactor vestigial-like protein 2, transcript variant X4
transcription cofactor vestigial-like protein 2 isoform X2
transcription cofactor vestigial-like protein 2 isoform X1
transcription cofactor vestigial-like protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sodium/potassium transporting ATPase interacting 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium/potassium transporting ATPase interacting 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 isoform X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 isoform X2
sodium/potassium transporting ATPase interacting 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 isoform X3
sodium/potassium transporting ATPase interacting 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 isoform X4
rho-related GTP-binding protein RhoB-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pumilio homolog 1-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00188
COORDINATES: nucleotide motif:Rfam:12.0:RF00598
glutathione hydrolase 1 proenzyme-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutathione hydrolase 1 proenzyme-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutathione hydrolase 1 proenzyme-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutathione hydrolase 1 proenzyme-like isoform X1
glutathione hydrolase 1 proenzyme-like isoform X3
glutathione hydrolase 1 proenzyme-like isoform X2
lysosomal-associated transmembrane protein 4A-like, transcript variant X1
lysosomal-associated transmembrane protein 4A-like, transcript variant X2
lysosomal-associated transmembrane protein 4A-like isoform X1
lysosomal-associated transmembrane protein 4A-like isoform X2
protein phosphatase 1, regulatory subunit 8a
COORDINATES: nucleotide motif:Rfam:12.0:RF00553
tRNA selenocysteine 1-associated protein 1-like, transcript variant X4
tRNA selenocysteine 1-associated protein 1-like, transcript variant X1
tRNA selenocysteine 1-associated protein 1-like, transcript variant X2
tRNA selenocysteine 1-associated protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
tRNA selenocysteine 1-associated protein 1-like isoform X1
tRNA selenocysteine 1-associated protein 1-like isoform X2
tRNA selenocysteine 1-associated protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tRNA selenocysteine 1-associated protein 1-like, transcript variant X5
tRNA selenocysteine 1-associated protein 1-like isoform X4
erythrocyte membrane protein band 4.1a, transcript variant X2
erythrocyte membrane protein band 4.1a, transcript variant X5
erythrocyte membrane protein band 4.1a, transcript variant X4
erythrocyte membrane protein band 4.1a, transcript variant X8
erythrocyte membrane protein band 4.1a, transcript variant X10
erythrocyte membrane protein band 4.1a, transcript variant X12
erythrocyte membrane protein band 4.1a, transcript variant X9
erythrocyte membrane protein band 4.1a, transcript variant X13
erythrocyte membrane protein band 4.1a, transcript variant X3
erythrocyte membrane protein band 4.1a, transcript variant X11
erythrocyte membrane protein band 4.1a, transcript variant X14
erythrocyte membrane protein band 4.1a, transcript variant X16
erythrocyte membrane protein band 4.1a, transcript variant X6
erythrocyte membrane protein band 4.1a, transcript variant X1
erythrocyte membrane protein band 4.1a, transcript variant X7
erythrocyte membrane protein band 4.1a, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
erythrocyte membrane protein band 4.1a, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/arginine-rich splicing factor 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
serine/arginine-rich splicing factor 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
serine/arginine-rich splicing factor 4-like isoform X1
serine/arginine-rich splicing factor 4-like isoform X2
transmembrane protein 244-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane protein 244-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane protein 244-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 244-like isoform X2
transmembrane protein 244-like isoform X1
transmembrane protein 244-like isoform X3
mitochondrial trans-2-enoyl-CoA reductase
enoyl-[acyl-carrier-protein] reductase, mitochondrial
receptor-type tyrosine-protein phosphatase U-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein THEMIS-like, transcript variant X1
protein THEMIS-like, transcript variant X2
replication protein A 32 kDa subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acid sphingomyelinase-like phosphodiesterase 3b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
acid sphingomyelinase-like phosphodiesterase 3b isoform X1
acid sphingomyelinase-like phosphodiesterase 3b isoform X2
acid sphingomyelinase-like phosphodiesterase 3b isoform X3
XK-related protein 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
XK-related protein 8-like, transcript variant X2
XK-related protein 8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC122563523, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122563523, transcript variant X1
eyes absent homolog 3-like, transcript variant X1
eyes absent homolog 3-like, transcript variant X3
eyes absent homolog 3-like, transcript variant X2
STKc_SGK domain-containing protein, transcript variant X4
STKc_SGK domain-containing protein, transcript variant X3
STKc_SGK domain-containing protein, transcript variant X2
STKc_SGK domain-containing protein, transcript variant X1
STKc_SGK domain-containing protein isoform X2
STKc_SGK domain-containing protein isoform X1
STKc_SGK domain-containing protein isoform X3
nuclear receptor coactivator 7, transcript variant X2
nuclear receptor coactivator 7, transcript variant X10
nuclear receptor coactivator 7, transcript variant X1
nuclear receptor coactivator 7, transcript variant X9
nuclear receptor coactivator 7, transcript variant X8
nuclear receptor coactivator 7, transcript variant X4
nuclear receptor coactivator 7, transcript variant X11
nuclear receptor coactivator 7, transcript variant X7
nuclear receptor coactivator 7, transcript variant X3
nuclear receptor coactivator 7, transcript variant X5
nuclear receptor coactivator 7, transcript variant X6
nuclear receptor coactivator 7 isoform X1
nuclear receptor coactivator 7 isoform X2
nuclear receptor coactivator 7 isoform X3
nuclear receptor coactivator 7 isoform X5
nuclear receptor coactivator 7 isoform X4
dynein light chain Tctex-type 1, transcript variant X2
dynein light chain Tctex-type 1, transcript variant X3
dynein light chain Tctex-type 1, transcript variant X1
dynein light chain Tctex-type 1 isoform X3
dynein light chain Tctex-type 1 isoform X2
dynein light chain Tctex-type 1 isoform X1
transmembrane and coiled-coil domain-containing protein 2-like, transcript variant X7
transmembrane and coiled-coil domain-containing protein 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 2-like, transcript variant X5
transmembrane and coiled-coil domain-containing protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 2-like, transcript variant X2
transmembrane and coiled-coil domain-containing protein 2-like, transcript variant X1
transmembrane and coiled-coil domain-containing protein 2-like isoform X2
uncharacterized protein LOC122563531 isoform X1
transmembrane and coiled-coil domain-containing protein 2-like, transcript variant X3
uncharacterized protein LOC122563531 isoform X3
lysine (K)-specific demethylase 1a, transcript variant X3
lysine-specific histone demethylase 1A isoform X3
lysine (K)-specific demethylase 1a, transcript variant X4
lysine (K)-specific demethylase 1a, transcript variant X1
lysine (K)-specific demethylase 1a, transcript variant X2
lysine-specific histone demethylase 1A isoform X1
lysine-specific histone demethylase 1A isoform X2
lysine-specific histone demethylase 1A isoform X4
5-hydroxytryptamine receptor 1D-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-hydroxytryptamine receptor 1D-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5-hydroxytryptamine receptor 1D-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
5-hydroxytryptamine receptor 1D-like, transcript variant X4
5-hydroxytryptamine receptor 1D-like, transcript variant X2
5-hydroxytryptamine receptor 1D-like, transcript variant X6
5-hydroxytryptamine receptor 1D-like, transcript variant X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
leucine zipper protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
leucine zipper protein 1, transcript variant X2
leucine zipper protein 1, transcript variant X1
leucine zipper protein 1, transcript variant X3
uncharacterized LOC122563539, transcript variant X2
uncharacterized LOC122563539, transcript variant X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X4
heterogeneous nuclear ribonucleoprotein R, transcript variant X2
heterogeneous nuclear ribonucleoprotein R, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R, transcript variant X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X5
heterogeneous nuclear ribonucleoprotein R isoform X1
heterogeneous nuclear ribonucleoprotein R isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00147
small nucleolar RNA Z195/SNORD33/SNORD32 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00133
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DnaJ (Hsp40) homolog, subfamily C, member 8
platelet-activating factor receptor, transcript variant X3
platelet-activating factor receptor, transcript variant X2
platelet-activating factor receptor, transcript variant X1
PARK2 co-regulated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PARK2 co-regulated, transcript variant X2
parkin coregulated gene protein isoform X1
parkin coregulated gene protein isoform X2
uncharacterized LOC122563544, transcript variant X2
uncharacterized LOC122563544, transcript variant X1
uncharacterized LOC122563544, transcript variant X3
uncharacterized LOC122563544, transcript variant X4
QKI, KH domain containing, RNA binding a, transcript variant X6
QKI, KH domain containing, RNA binding a, transcript variant X1
QKI, KH domain containing, RNA binding a, transcript variant X5
QKI, KH domain containing, RNA binding a, transcript variant X3
QKI, KH domain containing, RNA binding a, transcript variant X8
QKI, KH domain containing, RNA binding a, transcript variant X7
QKI, KH domain containing, RNA binding a, transcript variant X2
QKI, KH domain containing, RNA binding a, transcript variant X4
uncharacterized LOC122563546, transcript variant X2
uncharacterized LOC122563546, transcript variant X1
uncharacterized LOC122563546, transcript variant X3
uncharacterized LOC122563414, transcript variant X1
uncharacterized LOC122563414, transcript variant X2
U5 small nuclear ribonucleoprotein 40 kDa protein
F-box only protein 39-like, transcript variant X1
F-box only protein 39-like, transcript variant X3
F-box only protein 39-like, transcript variant X2
major facilitator superfamily domain containing 2ab
sodium-dependent lysophosphatidylcholine symporter 1-B
uncharacterized LOC122563553, transcript variant X2
uncharacterized LOC122563553, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
penta-EF-hand domain containing 1, transcript variant X1
penta-EF-hand domain containing 1, transcript variant X2
Zinc finger protein 706-like, transcript variant X2
Zinc finger protein 706-like, transcript variant X1
Zinc finger protein 706-like, transcript variant X3
homeobox-containing protein 1-like, transcript variant X2
homeobox-containing protein 1-like, transcript variant X7
homeobox-containing protein 1-like, transcript variant X1
homeobox-containing protein 1-like, transcript variant X3
homeobox-containing protein 1-like, transcript variant X5
homeobox-containing protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
homeobox-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
homeobox-containing protein 1-like isoform X1
homeobox-containing protein 1-like isoform X2
homeobox-containing protein 1-like isoform X4
homeobox-containing protein 1-like isoform X3
homeobox-containing protein 1-like isoform X5
peptidylprolyl isomerase E (cyclophilin E), transcript variant X1
peptidylprolyl isomerase E (cyclophilin E), transcript variant X2
peptidylprolyl isomerase E (cyclophilin E), transcript variant X3
peptidyl-prolyl cis-trans isomerase E isoform X1
peptidyl-prolyl cis-trans isomerase E isoform X3
peptidyl-prolyl cis-trans isomerase E isoform X2
poly(A) binding protein, cytoplasmic 4 (inducible form), transcript variant X1
poly(A) binding protein, cytoplasmic 4 (inducible form), transcript variant X2
poly(A) binding protein, cytoplasmic 4 (inducible form), transcript variant X3
polyadenylate-binding protein 4 isoform X2
polyadenylate-binding protein 4 isoform X1
polyadenylate-binding protein 4 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00431
protein disulfide isomerase family A, member 6
adenylate kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
adenylate kinase 2, transcript variant X2
adenylate kinase 2, mitochondrial isoform X2
adenylate kinase 2, mitochondrial isoform X1
ring finger protein 19B, transcript variant X3
ring finger protein 19B, transcript variant X2
ring finger protein 19B, transcript variant X1
ring finger protein 19B, transcript variant X4
ring finger protein 19B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF19B isoform X1
E3 ubiquitin-protein ligase RNF19B isoform X2
E3 ubiquitin-protein ligase RNF19B isoform X3
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like, transcript variant X3
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like, transcript variant X4
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like isoform X2
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like isoform X1
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like isoform X3
synaptotagmin-like protein 2, transcript variant X2
synaptotagmin-like protein 2, transcript variant X1
WD and tetratricopeptide repeats protein 1
V-type proton ATPase subunit d 2-like, transcript variant X2
V-type proton ATPase subunit d 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
V-type proton ATPase subunit d 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
V-type proton ATPase subunit d 2-like isoform X1
V-type proton ATPase subunit d 2-like isoform X2
V-type proton ATPase subunit d 2-like isoform X3
keratinocyte differentiation factor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
nuclear receptor subfamily 0 group B member 2-like
GPN-loop GTPase 2, transcript variant X1
GPN-loop GTPase 2, transcript variant X2
dehydrodolichyl diphosphate synthase, transcript variant X1
dehydrodolichyl diphosphate synthase, transcript variant X2
dehydrodolichyl diphosphate synthase complex subunit DHDDS
uncharacterized LOC122563576, transcript variant X3
uncharacterized LOC122563576, transcript variant X2
uncharacterized LOC122563576, transcript variant X4
uncharacterized LOC122563576, transcript variant X1
AT rich interactive domain 1Ab (SWI-like), transcript variant X1
AT rich interactive domain 1Ab (SWI-like), transcript variant X2
AT rich interactive domain 1Ab (SWI-like), transcript variant X4
AT rich interactive domain 1Ab (SWI-like), transcript variant X3
AT-rich interactive domain-containing protein 1A isoform X1
AT-rich interactive domain-containing protein 1A isoform X2
AT-rich interactive domain-containing protein 1A isoform X4
AT-rich interactive domain-containing protein 1A isoform X3
phosphatidylinositol glycan anchor biosynthesis, class V, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis, class V, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis, class V, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
palmitoyltransferase ZDHHC18-A isoform X1
palmitoyltransferase ZDHHC18-A isoform X3
phosphatidylinositol glycan anchor biosynthesis, class V, transcript variant X3
palmitoyltransferase ZDHHC18-A isoform X2
palmitoyltransferase ZDHHC18-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
palmitoyltransferase ZDHHC18-like, transcript variant X3
palmitoyltransferase ZDHHC18-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
palmitoyltransferase ZDHHC18-like, transcript variant X1
palmitoyltransferase ZDHHC18-like, transcript variant X2
palmitoyltransferase ZDHHC18-like isoform X1
palmitoyltransferase ZDHHC18-like isoform X2
palmitoyltransferase ZDHHC18-like isoform X4
palmitoyltransferase ZDHHC18-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cation channel sperm-associated protein 4-like, transcript variant X2
cation channel sperm-associated protein 4-like, transcript variant X1
cation channel sperm-associated protein 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cation channel sperm-associated protein 4-like isoform X3
cation channel sperm-associated protein 4-like isoform X2
cation channel sperm-associated protein 4-like isoform X1
connector enhancer of kinase suppressor of Ras 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
connector enhancer of kinase suppressor of Ras 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
connector enhancer of kinase suppressor of Ras 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
connector enhancer of kinase suppressor of ras 1 isoform X2
connector enhancer of kinase suppressor of ras 1 isoform X1
connector enhancer of kinase suppressor of ras 1 isoform X3
ribosomal protein S6 kinase 2 alpha-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ribosomal protein S6 kinase 2 alpha-like, transcript variant X7
ribosomal protein S6 kinase 2 alpha-like, transcript variant X1
ribosomal protein S6 kinase 2 alpha-like, transcript variant X3
ribosomal protein S6 kinase 2 alpha-like isoform X1
ribosomal protein S6 kinase 2 alpha-like isoform X3
ribosomal protein S6 kinase 2 alpha-like isoform X6
ribosomal protein S6 kinase 2 alpha-like isoform X7
ribosomal protein S6 kinase 2 alpha-like, transcript variant X2
ribosomal protein S6 kinase 2 alpha-like isoform X2
ribosomal protein S6 kinase 2 alpha-like, transcript variant X5
ribosomal protein S6 kinase 2 alpha-like isoform X5
ribosomal protein S6 kinase 2 alpha-like, transcript variant X4
ribosomal protein S6 kinase alpha-2-like isoform X4
ribosomal protein S6 kinase 2 alpha-like, transcript variant X8
ribosomal protein S6 kinase 2 alpha-like isoform X8
centrosomal protein 85, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
centrosomal protein 85, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
centrosomal protein 85, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
centrosomal protein 85, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
centrosomal protein 85, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
centrosomal protein of 85 kDa isoform X1
centrosomal protein of 85 kDa isoform X4
centrosomal protein of 85 kDa isoform X2
centrosomal protein 85, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
centrosomal protein of 85 kDa isoform X3
SH3 domain-binding glutamic acid-rich-like protein 3
UBX domain protein 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UBX domain protein 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UBX domain-containing protein 11 isoform X1
UBX domain-containing protein 11 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein lin-28 homolog B-like
PR domain zinc finger protein 1-like, transcript variant X1
PR domain zinc finger protein 1-like isoform X1
PR domain zinc finger protein 1-like, transcript variant X2
PR domain zinc finger protein 1-like isoform X2
PR domain zinc finger protein 1-like, transcript variant X3
PR domain zinc finger protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
beta/gamma crystallin domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
DNA-binding protein inhibitor ID-3-B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122563594, transcript variant X1
uncharacterized LOC122563594, transcript variant X2
uncharacterized LOC122563594, transcript variant X3
uncharacterized LOC122563595, transcript variant X1
uncharacterized LOC122563595, transcript variant X2
YTH N(6)-methyladenosine RNA binding protein 2, transcript variant X1
YTH N(6)-methyladenosine RNA binding protein 2, transcript variant X2
YTH domain-containing family protein 2 isoform X2
YTH domain-containing family protein 2 isoform X1
glucocorticoid modulatory element-binding protein 1-like
dnaJ homolog subfamily C member 5-like, transcript variant X2
dnaJ homolog subfamily C member 5-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM63-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM63-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM63-like isoform X1
E3 ubiquitin-protein ligase TRIM63-like isoform X2
zinc transporter 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc transporter 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc transporter 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc transporter 2-like, transcript variant X4
mediator of RNA polymerase II transcription subunit 30-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 30-like, transcript variant X3
mediator of RNA polymerase II transcription subunit 30-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 30-like
platelet-activating factor acetylhydrolase 2, cytoplasmic-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
platelet-activating factor acetylhydrolase 2, cytoplasmic-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
platelet-activating factor acetylhydrolase 2, cytoplasmic-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
platelet-activating factor acetylhydrolase 2, cytoplasmic-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
platelet-activating factor acetylhydrolase 2, cytoplasmic-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
platelet-activating factor acetylhydrolase 2, cytoplasmic-like isoform X1
platelet-activating factor acetylhydrolase 2, cytoplasmic-like isoform X2
platelet-activating factor acetylhydrolase 2, cytoplasmic-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
progestin and adipoQ receptor family member VII, b, transcript variant X2
progestin and adipoQ receptor family member VII, b, transcript variant X1
progestin and adipoQ receptor family member VII, b, transcript variant X3
uncharacterized LOC122563607, transcript variant X1
uncharacterized LOC122563607, transcript variant X3
uncharacterized LOC122563607, transcript variant X2
PDLIM1 interacting kinase 1 like, transcript variant X1
PDLIM1 interacting kinase 1 like, transcript variant X2
family with sequence similarity 110 member D, transcript variant X4
family with sequence similarity 110 member D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
family with sequence similarity 110 member D, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 110 member D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
family with sequence similarity 110 member D, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122563612, transcript variant X2
uncharacterized LOC122563612, transcript variant X3
uncharacterized LOC122563612, transcript variant X1
uncharacterized protein LOC122563612 isoform X3
uncharacterized protein LOC122563612 isoform X2
uncharacterized protein LOC122563612 isoform X1
uncharacterized LOC122563611, transcript variant X2
uncharacterized LOC122563611, transcript variant X3
uncharacterized LOC122563611, transcript variant X4
uncharacterized protein LOC122563611 isoform X2
uncharacterized LOC122563611, transcript variant X1
uncharacterized protein LOC122563611 isoform X1
lysophospholipid acyltransferase 2-like, transcript variant X2
lysophospholipid acyltransferase 2-like, transcript variant X1
lysophospholipid acyltransferase 2-like, transcript variant X3
lysophospholipid acyltransferase 2-like isoform X1
lysophospholipid acyltransferase 2-like isoform X2
E2F transcription factor 2, transcript variant X1
E2F transcription factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2-like
transcription elongation factor A (SII), 3, transcript variant X2
transcription elongation factor A (SII), 3, transcript variant X1
transcription elongation factor A (SII), 3, transcript variant X3
transcription elongation factor A protein 3 isoform X1
transcription elongation factor A protein 3 isoform X2
regulator of G-protein signaling 17-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122563620, transcript variant X2
uncharacterized LOC122563620, transcript variant X1
regulator of chromosome condensation 1, transcript variant X2
regulator of chromosome condensation 1, transcript variant X3
regulator of chromosome condensation 1, transcript variant X1
regulator of chromosome condensation 1, transcript variant X4
regulator of chromosome condensation isoform X2
regulator of chromosome condensation isoform X1
regulator of chromosome condensation isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00045
phosphatase and actin regulator 4b, transcript variant X5
phosphatase and actin regulator 4b, transcript variant X4
phosphatase and actin regulator 4b, transcript variant X6
phosphatase and actin regulator 4b, transcript variant X3
phosphatase and actin regulator 4b, transcript variant X2
phosphatase and actin regulator 4b, transcript variant X1
phosphatase and actin regulator 4b, transcript variant X7
phosphatase and actin regulator 4B isoform X4
phosphatase and actin regulator 4B isoform X3
phosphatase and actin regulator 4B isoform X5
phosphatase and actin regulator 4B isoform X2
phosphatase and actin regulator 4B isoform X1
transcription factor HIVEP3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor HIVEP3, transcript variant X4
transcription factor HIVEP3, transcript variant X1
transcription factor HIVEP3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122563428, transcript variant X2
uncharacterized LOC122563428, transcript variant X4
uncharacterized LOC122563428, transcript variant X1
uncharacterized LOC122563428, transcript variant X3
fatty acid-binding protein, brain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
fatty acid-binding protein, brain-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fatty acid-binding protein, brain-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
fatty acid-binding protein, brain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
fatty acid-binding protein, brain-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fatty acid-binding protein, brain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fatty acid-binding protein, brain-like isoform X1
fatty acid-binding protein, brain-like isoform X3
fatty acid-binding protein, brain-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
fatty acid-binding protein, brain-like isoform X2
amine sulfotransferase-like, transcript variant X2
amine sulfotransferase-like, transcript variant X1
amine sulfotransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
amine sulfotransferase-like, transcript variant X4
uncharacterized LOC122563633, transcript variant X2
uncharacterized LOC122563633, transcript variant X1
trafficking protein particle complex subunit 3, transcript variant X1
trafficking protein particle complex subunit 3, transcript variant X2
trafficking protein particle complex subunit 3, transcript variant X3
trafficking protein particle complex subunit 3, transcript variant X4
trafficking protein particle complex subunit 3 isoform X1
trafficking protein particle complex subunit 3 isoform X2
trafficking protein particle complex subunit 3 isoform X3
trafficking protein particle complex subunit 3 isoform X4
collagen, type VIII, alpha 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
collagen, type VIII, alpha 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
collagen, type VIII, alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
collagen, type VIII, alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
collagen, type VIII, alpha 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC122563430, transcript variant X1
uncharacterized LOC122563430, transcript variant X2
fibronectin type III domain containing 5a, transcript variant X2
fibronectin type III domain containing 5a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibronectin type III domain-containing protein 5 isoform X1
fibronectin type III domain-containing protein 5 isoform X2
low density lipoprotein receptor adaptor protein 1b, transcript variant X2
low density lipoprotein receptor adaptor protein 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
low density lipoprotein receptor adapter protein 1b
Rh blood group, D antigen, transcript variant X1
Rh blood group, D antigen, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
small nuclear ribonucleoprotein polypeptide C
arginine/serine-rich protein 1, transcript variant X2
arginine/serine-rich protein 1, transcript variant X3
arginine/serine-rich protein 1, transcript variant X4
arginine/serine-rich protein 1, transcript variant X1
uncharacterized LOC122563646, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC122563646, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122563647, transcript variant X2
uncharacterized LOC122563647, transcript variant X1
RUNX family transcription factor 3, transcript variant X1
RUNX family transcription factor 3, transcript variant X2
runt-related transcription factor 3 isoform X1
runt-related transcription factor 3 isoform X2
chloride intracellular channel protein 4, transcript variant X1
chloride intracellular channel protein 4, transcript variant X2
chloride intracellular channel protein 4 isoform X1
chloride intracellular channel protein 4 isoform X2
serine/arginine repetitive matrix 1, transcript variant X2
serine/arginine repetitive matrix 1, transcript variant X4
serine/arginine repetitive matrix 1, transcript variant X6
serine/arginine repetitive matrix 1, transcript variant X5
serine/arginine repetitive matrix 1, transcript variant X1
serine/arginine repetitive matrix 1, transcript variant X3
serine/arginine repetitive matrix 1, transcript variant X7
serine/arginine repetitive matrix protein 1 isoform X2
serine/arginine repetitive matrix protein 1 isoform X4
serine/arginine repetitive matrix protein 1 isoform X6
serine/arginine repetitive matrix protein 1 isoform X5
serine/arginine repetitive matrix protein 1 isoform X1
serine/arginine repetitive matrix protein 1 isoform X3
serine/arginine repetitive matrix protein 1 isoform X7
non-compact myelin associated protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
non-compact myelin associated protein, transcript variant X1
non-compact myelin associated protein, transcript variant X2
noncompact myelin-associated protein isoform X1
noncompact myelin-associated protein isoform X2
regulator of calcineurin 3, transcript variant X6
regulator of calcineurin 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulator of calcineurin 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of calcineurin 3, transcript variant X1
regulator of calcineurin 3, transcript variant X2
regulator of calcineurin 3, transcript variant X7
regulator of calcineurin 3, transcript variant X5
keratinocyte-associated protein 3-like, transcript variant X1
keratinocyte-associated protein 3-like isoform X1
keratinocyte-associated protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
keratinocyte-associated protein 3-like isoform X2
hippocalcin-like protein 1, transcript variant X2
hippocalcin-like protein 1, transcript variant X1
hippocalcin-like protein 1, transcript variant X3
sperm-tail PG-rich repeat containing 1, transcript variant X4
ribonucleotide reductase M2 polypeptide, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ribonucleotide reductase M2 polypeptide, transcript variant X2
ribonucleotide reductase M2 polypeptide, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ribonucleoside-diphosphate reductase subunit M2 isoform X2
ribonucleoside-diphosphate reductase subunit M2 isoform X1
ribonucleoside-diphosphate reductase subunit M2 isoform X3
ribonucleotide reductase M2 polypeptide, transcript variant X4
ribonucleoside-diphosphate reductase subunit M2 isoform X4
sperm-tail PG-rich repeat containing 1, transcript variant X1
sperm-tail PG-rich repeat containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sperm-tail PG-rich repeat containing 1, transcript variant X3
O(6)-methylguanine-induced apoptosis 2 isoform X1
O(6)-methylguanine-induced apoptosis 2 isoform X2
grainyhead-like protein 3 homolog, transcript variant X4
grainyhead-like protein 3 homolog, transcript variant X3
grainyhead-like protein 3 homolog, transcript variant X5
grainyhead-like protein 3 homolog, transcript variant X1
grainyhead-like protein 3 homolog, transcript variant X2
grainyhead-like protein 3 homolog, transcript variant X6
grainyhead-like protein 3 homolog isoform X2
grainyhead-like protein 3 homolog isoform X1
grainyhead-like protein 3 homolog isoform X3
grainyhead-like protein 3 homolog isoform X4
uncharacterized LOC122563663, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122563663, transcript variant X2
transcription factor GATA-4-like, transcript variant X2
transcription factor GATA-4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription factor GATA-4-like, transcript variant X1
transcription factor GATA-4-like isoform X3
transcription factor GATA-4-like isoform X1
transcription factor GATA-4-like isoform X2
dyslexia-associated protein KIAA0319-like protein, transcript variant X6
dyslexia-associated protein KIAA0319-like protein, transcript variant X3
dyslexia-associated protein KIAA0319-like protein, transcript variant X4
dyslexia-associated protein KIAA0319-like protein, transcript variant X5
dyslexia-associated protein KIAA0319-like protein, transcript variant X1
dyslexia-associated protein KIAA0319-like protein, transcript variant X2
dyslexia-associated protein KIAA0319-like protein isoform X5
dyslexia-associated protein KIAA0319-like protein isoform X4
dyslexia-associated protein KIAA0319-like protein isoform X1
dyslexia-associated protein KIAA0319-like protein isoform X2
dyslexia-associated protein KIAA0319-like protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
UPF0500 protein C1orf216 homolog, transcript variant X6
UPF0500 protein C1orf216 homolog, transcript variant X7
UPF0500 protein C1orf216 homolog, transcript variant X5
UPF0500 protein C1orf216 homolog, transcript variant X2
UPF0500 protein C1orf216 homolog, transcript variant X3
UPF0500 protein C1orf216 homolog, transcript variant X4
UPF0500 protein C1orf216 homolog, transcript variant X1
transcription factor AP-2 epsilon, transcript variant X2
transcription factor AP-2 epsilon, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcription factor AP-2-epsilon isoform X1
transcription factor AP-2-epsilon isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58% coverage of the annotated genomic feature by RNAseq alignments
protein argonaute-4, transcript variant X1
protein argonaute-4, transcript variant X2
protein argonaute-4, transcript variant X3
protein argonaute-4, transcript variant X4
protein argonaute-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein argonaute-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122563676, transcript variant X2
uncharacterized LOC122563676, transcript variant X1
protein argonaute-3, transcript variant X1
protein argonaute-3, transcript variant X2
protein argonaute-3, transcript variant X3
tektin 2 (testicular), transcript variant X1
tektin 2 (testicular), transcript variant X2
tektin 2 (testicular), transcript variant X3
CAP, adenylate cyclase-associated protein 1 (yeast)
palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile)
palmitoyl-protein thioesterase 1-like, transcript variant X1
palmitoyl-protein thioesterase 1-like, transcript variant X2
palmitoyl-protein thioesterase 1-like isoform X1
palmitoyl-protein thioesterase 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
UDP-galactose-4-epimerase, transcript variant X2
UDP-galactose-4-epimerase, transcript variant X1
UDP-galactose-4-epimerase, transcript variant X3
UDP-galactose-4-epimerase, transcript variant X4
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1, transcript variant X2
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1, transcript variant X1
PITH domain-containing protein 1 isoform X2
PITH domain-containing protein 1 isoform X1
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X2
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X1
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X3
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X2
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X1
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X3
bone morphogenetic protein 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bone morphogenetic protein 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bone morphogenetic protein 7-like isoform X2
bone morphogenetic protein 7-like isoform X1
bone morphogenetic protein 7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bone morphogenetic protein 7-like isoform X3
microtubule actin crosslinking factor 1a, transcript variant X19
microtubule actin crosslinking factor 1a, transcript variant X23
microtubule actin crosslinking factor 1a, transcript variant X18
microtubule actin crosslinking factor 1a, transcript variant X12
microtubule actin crosslinking factor 1a, transcript variant X24
microtubule actin crosslinking factor 1a, transcript variant X22
microtubule actin crosslinking factor 1a, transcript variant X21
microtubule actin crosslinking factor 1a, transcript variant X20
microtubule actin crosslinking factor 1a, transcript variant X17
microtubule actin crosslinking factor 1a, transcript variant X13
microtubule actin crosslinking factor 1a, transcript variant X8
microtubule actin crosslinking factor 1a, transcript variant X11
microtubule actin crosslinking factor 1a, transcript variant X10
microtubule actin crosslinking factor 1a, transcript variant X15
microtubule actin crosslinking factor 1a, transcript variant X14
microtubule actin crosslinking factor 1a, transcript variant X9
microtubule actin crosslinking factor 1a, transcript variant X2
microtubule actin crosslinking factor 1a, transcript variant X4
microtubule actin crosslinking factor 1a, transcript variant X1
microtubule actin crosslinking factor 1a, transcript variant X5
microtubule actin crosslinking factor 1a, transcript variant X3
microtubule actin crosslinking factor 1a, transcript variant X7
microtubule actin crosslinking factor 1a, transcript variant X6
microtubule actin crosslinking factor 1a, transcript variant X16
microtubule-actin cross-linking factor 1 isoform X21
microtubule-actin cross-linking factor 1 isoform X20
microtubule-actin cross-linking factor 1 isoform X17
microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 isoform X23
microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 isoform X19
microtubule-actin cross-linking factor 1 isoform X24
microtubule-actin cross-linking factor 1 isoform X22
microtubule-actin cross-linking factor 1 isoform X18
microtubule-actin cross-linking factor 1 isoform X12
microtubule-actin cross-linking factor 1 isoform X13
microtubule-actin cross-linking factor 1 isoform X16
microtubule-actin cross-linking factor 1 isoform X5
microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 isoform X15
microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 isoform X14
microtubule-actin cross-linking factor 1 isoform X9
microtubule-actin cross-linking factor 1 isoform X3
microtubule-actin cross-linking factor 1 isoform X2
microtubule-actin cross-linking factor 1 isoform X11
microtubule-actin cross-linking factor 1 isoform X7
microtubule-actin cross-linking factor 1 isoform X4
microtubule-actin cross-linking factor 1 isoform X10
microtubule-actin cross-linking factor 1 isoform X6
microtubule-actin cross-linking factor 1 isoform X8
microtubule-actin cross-linking factor 1 isoform X1
transfer RNA phenylalanine (anticodon AAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
NADH:ubiquinone oxidoreductase subunit S5, transcript variant X1
NADH:ubiquinone oxidoreductase subunit S5, transcript variant X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 5
hairy/enhancer-of-split related with YRPW motif protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 8B-like, transcript variant X5
zinc finger and BTB domain-containing protein 8B-like, transcript variant X2
zinc finger and BTB domain-containing protein 8B-like, transcript variant X4
zinc finger and BTB domain-containing protein 8B-like, transcript variant X1
zinc finger and BTB domain-containing protein 8B-like, transcript variant X3
zinc finger and BTB domain-containing protein 8B-like
zinc finger and BTB domain-containing protein 8A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 8A-like isoform X1
zinc finger and BTB domain-containing protein 8A-like, transcript variant X2
zinc finger and BTB domain-containing protein 8A-like isoform X2
zinc finger and BTB domain-containing protein 8A-like, transcript variant X3
tissue alpha-L-fucosidase-like, transcript variant X1
zinc finger and BTB domain-containing protein 8A-like, transcript variant X8
zinc finger and BTB domain-containing protein 8A-like, transcript variant X7
zinc finger and BTB domain-containing protein 8A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 8A-like, transcript variant X9
zinc finger and BTB domain-containing protein 8A-like, transcript variant X6
zinc finger and BTB domain-containing protein 8A-like, transcript variant X12
zinc finger and BTB domain-containing protein 8A-like, transcript variant X11
zinc finger and BTB domain-containing protein 8A-like, transcript variant X13
zinc finger and BTB domain-containing protein 8A-like, transcript variant X10
zinc finger and BTB domain-containing protein 8A-like, transcript variant X5
zinc finger and BTB domain-containing protein 8A-like isoform X3
tissue alpha-L-fucosidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cannabinoid receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cannabinoid receptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cannabinoid receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rhomboid, veinlet-like 2 (Drosophila), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
rhomboid, veinlet-like 2 (Drosophila), transcript variant X3
rhomboid, veinlet-like 2 (Drosophila), transcript variant X2
gap junction protein alpha 9a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gap junction protein alpha 9a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 3, transcription factor 1
UTP11 small subunit processome component
probable U3 small nucleolar RNA-associated protein 11
uncharacterized LOC122563710, transcript variant X1
uncharacterized LOC122563710, transcript variant X2
four and a half LIM domains 3a, transcript variant X5
four and a half LIM domains 3a, transcript variant X3
four and a half LIM domains 3a, transcript variant X4
four and a half LIM domains 3a, transcript variant X2
four and a half LIM domains 3a, transcript variant X6
four and a half LIM domains 3a, transcript variant X1
interferon alpha-inducible protein 6-like
interferon alpha-inducible protein 27-like protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
interferon alpha-inducible protein 27-like protein 2, transcript variant X2
interferon alpha-inducible protein 27-like protein 2 isoform X2
interferon alpha-inducible protein 27-like protein 2A isoform X1
interferon alpha-inducible protein 27-like protein 2A
interferon alpha-inducible protein 27-like protein 2A, transcript variant X1
interferon alpha-inducible protein 27-like protein 2A, transcript variant X2
interferon alpha-inducible protein 27-like protein 2A isoform X2
interferon alpha-inducible protein 27-like protein 2, transcript variant X4
interferon alpha-inducible protein 27-like protein 2, transcript variant X3
interferon alpha-inducible protein 27-like protein 2 isoform X1
small integral membrane protein 12, transcript variant X1
small integral membrane protein 12, transcript variant X2
discs, large (Drosophila) homolog-associated protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
discs, large (Drosophila) homolog-associated protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
discs, large (Drosophila) homolog-associated protein 3, transcript variant X3
discs, large (Drosophila) homolog-associated protein 3, transcript variant X6
discs, large (Drosophila) homolog-associated protein 3, transcript variant X1
discs, large (Drosophila) homolog-associated protein 3, transcript variant X2
disks large-associated protein 3 isoform X2
disks large-associated protein 3 isoform X1
platelet-activating factor receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
platelet-activating factor receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
platelet-activating factor receptor-like, transcript variant X2
platelet-activating factor receptor-like, transcript variant X4
platelet-activating factor receptor-like, transcript variant X5
platelet-activating factor receptor-like
transmembrane protein 35B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 35B-like isoform X2
transmembrane protein 35B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane protein 35B-like isoform X1
splicing factor, proline- and glutamine-rich-like, transcript variant X2
splicing factor, proline- and glutamine-rich-like, transcript variant X1
splicing factor, proline- and glutamine-rich-like
zinc finger MYM-type containing 4, tandem duplicate 1, transcript variant X3
zinc finger MYM-type containing 4, tandem duplicate 1, transcript variant X1
zinc finger MYM-type containing 4, tandem duplicate 1, transcript variant X2
zinc finger MYM-type containing 4, tandem duplicate 1, transcript variant X4
zinc finger MYM-type containing 4, tandem duplicate 1, transcript variant X5
zinc finger MYM-type protein 4 isoform X1
zinc finger MYM-type protein 4 isoform X3
zinc finger MYM-type protein 4 isoform X2
zinc finger MYM-type protein 4 isoform X4
zinc finger MYM-type protein 4 isoform X5
zinc finger MYM-type containing 4, tandem duplicate 1, transcript variant X6
zinc finger MYM-type containing 4, tandem duplicate 1, transcript variant X7
zinc finger MYM-type protein 4 isoform X6
zinc finger MYM-type protein 4 isoform X7
gap junction beta-3 protein-like, transcript variant X5
gap junction beta-3 protein-like, transcript variant X4
gap junction beta-3 protein-like, transcript variant X3
gap junction beta-3 protein-like, transcript variant X2
gap junction beta-3 protein-like, transcript variant X1
gap junction beta-4 protein-like isoform X1
gap junction beta-3 protein-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
gap junction beta-4 protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gap junction beta-4 protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gap junction beta-4 protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CUB and Sushi multiple domains 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
CUB and sushi domain-containing protein 1 isoform X2
CUB and Sushi multiple domains 2, transcript variant X1
CUB and sushi domain-containing protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
guanine nucleotide binding protein-like 2 (nucleolar)
dynein, axonemal, light intermediate chain 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
axonemal dynein light intermediate polypeptide 1
Smad nuclear interacting protein, transcript variant X1
Smad nuclear interacting protein, transcript variant X2
MYST/Esa1-associated factor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
MYST/Esa1-associated factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
MYST/Esa1-associated factor 6, transcript variant X3
MYST/Esa1-associated factor 6, transcript variant X4
chromatin modification-related protein MEAF6 isoform X1
chromatin modification-related protein MEAF6 isoform X2
chromatin modification-related protein MEAF6 isoform X3
chromatin modification-related protein MEAF6 isoform X4
uncharacterized LOC122563731, transcript variant X2
uncharacterized LOC122563731, transcript variant X1
uncharacterized LOC122563731, transcript variant X3
ribonuclease ZC3H12A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ribonuclease ZC3H12A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C1orf109 homolog
cell division cycle associated 8, transcript variant X2
cell division cycle associated 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
ephrin type-A receptor 7-like, transcript variant X2
ephrin type-A receptor 7-like, transcript variant X1
ephrin type-A receptor 7-like, transcript variant X3
ephrin type-A receptor 7-like isoform X3
ephrin type-A receptor 7-like isoform X2
ephrin type-A receptor 7-like isoform X1
ephrin type-A receptor 7-like, transcript variant X4
ephrin type-A receptor 7-like isoform X4
ephrin type-A receptor 7-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ephrin type-A receptor 7-like isoform X6
ephrin type-A receptor 7-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ephrin type-A receptor 7-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
glycoprotein endo-alpha-1,2-mannosidase-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
yrdC N(6)-threonylcarbamoyltransferase domain containing
yrdC domain-containing protein, mitochondrial
metal-regulatory transcription factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
metal-regulatory transcription factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inositol polyphosphate-5-phosphatase B, transcript variant X1
inositol polyphosphate-5-phosphatase B, transcript variant X2
inositol polyphosphate-5-phosphatase B, transcript variant X3
inositol polyphosphate-5-phosphatase B, transcript variant X4
inositol polyphosphate-5-phosphatase B, transcript variant X5
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X1
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X2
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X3
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X4
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X5
serine/threonine kinase 40, transcript variant X1
serine/threonine-protein kinase 40 isoform X1
serine/threonine kinase 40, transcript variant X2
serine/threonine-protein kinase 40 isoform X2
uncharacterized LOC122563743, transcript variant X1
uncharacterized LOC122563743, transcript variant X2
eva-1 homolog Ba (C. elegans), transcript variant X1
eva-1 homolog Ba (C. elegans), transcript variant X2
eva-1 homolog Ba (C. elegans), transcript variant X3
SH3 domain containing 21, transcript variant X7
SH3 domain containing 21, transcript variant X6
SH3 domain containing 21, transcript variant X5
SH3 domain containing 21, transcript variant X2
SH3 domain containing 21, transcript variant X3
SH3 domain containing 21, transcript variant X1
SH3 domain containing 21, transcript variant X4
SH3 domain-containing protein 21 isoform X7
SH3 domain-containing protein 21 isoform X6
SH3 domain-containing protein 21 isoform X5
SH3 domain-containing protein 21 isoform X2
SH3 domain-containing protein 21 isoform X3
SH3 domain-containing protein 21 isoform X1
SH3 domain-containing protein 21 isoform X4
thyroid hormone receptor-associated protein 3-like, transcript variant X2
thyroid hormone receptor-associated protein 3-like, transcript variant X7
thyroid hormone receptor-associated protein 3-like, transcript variant X6
thyroid hormone receptor-associated protein 3-like, transcript variant X9
thyroid hormone receptor-associated protein 3-like, transcript variant X1
thyroid hormone receptor-associated protein 3-like, transcript variant X3
thyroid hormone receptor-associated protein 3-like, transcript variant X5
thyroid hormone receptor-associated protein 3-like, transcript variant X4
thyroid hormone receptor-associated protein 3-like, transcript variant X8
thyroid hormone receptor-associated protein 3-like isoform X3
thyroid hormone receptor-associated protein 3-like isoform X2
thyroid hormone receptor-associated protein 3-like isoform X5
thyroid hormone receptor-associated protein 3-like isoform X1
thyroid hormone receptor-associated protein 3-like isoform X4
MAP7 domain containing 1a, transcript variant X2
MAP7 domain containing 1a, transcript variant X3
MAP7 domain containing 1a, transcript variant X1
MAP7 domain containing 1a, transcript variant X4
MAP7 domain-containing protein 1a isoform X3
MAP7 domain-containing protein 1a isoform X2
MAP7 domain-containing protein 1a isoform X1
MAP7 domain-containing protein 1a isoform X4
mitogen-activated protein kinase kinase kinase 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 5-like isoform X2
mitogen-activated protein kinase kinase kinase 5-like isoform X1
uncharacterized LOC122563749, transcript variant X2
uncharacterized LOC122563749, transcript variant X7
uncharacterized LOC122563749, transcript variant X4
uncharacterized LOC122563749, transcript variant X3
uncharacterized LOC122563749, transcript variant X5
uncharacterized LOC122563749, transcript variant X6
uncharacterized LOC122563749, transcript variant X1
U7 snRNA-associated Sm-like protein LSm10, transcript variant X1
U7 snRNA-associated Sm-like protein LSm10, transcript variant X3
U7 snRNA-associated Sm-like protein LSm10, transcript variant X2
U7 snRNA-associated Sm-like protein LSm10
protein tyrosine phosphatase type IVA 2-like, transcript variant X2
protein tyrosine phosphatase type IVA 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase type IVA 2-like
adhesion G protein-coupled receptor B2-like, transcript variant X4
adhesion G protein-coupled receptor B2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor B2-like, transcript variant X3
adhesion G protein-coupled receptor B2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor B2-like, transcript variant X6
adhesion G protein-coupled receptor B2-like, transcript variant X5
adhesion G protein-coupled receptor B2-like isoform X1
adhesion G protein-coupled receptor B2-like, transcript variant X7
adhesion G protein-coupled receptor B2-like isoform X2
C-reactive protein-like, transcript variant X1
C-reactive protein-like, transcript variant X2
tRNA isopentenyltransferase 1, transcript variant X3
tRNA isopentenyltransferase 1, transcript variant X4
tRNA isopentenyltransferase 1, transcript variant X1
tRNA dimethylallyltransferase isoform X3
tRNA dimethylallyltransferase isoform X1
tRNA isopentenyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
tRNA dimethylallyltransferase isoform X2
stromal membrane-associated protein 2-like, transcript variant X2
stromal membrane-associated protein 2-like, transcript variant X1
stromal membrane-associated protein 2-like isoform X2
stromal membrane-associated protein 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments
regulating synaptic membrane exocytosis protein 3-like, transcript variant X2
regulating synaptic membrane exocytosis protein 3-like, transcript variant X3
regulating synaptic membrane exocytosis protein 3-like, transcript variant X1
regulating synaptic membrane exocytosis protein 3-like
nuclear transcription factor Y, gamma, transcript variant X4
nuclear transcription factor Y, gamma, transcript variant X6
nuclear transcription factor Y, gamma, transcript variant X1
nuclear transcription factor Y, gamma, transcript variant X2
nuclear transcription factor Y, gamma, transcript variant X3
nuclear transcription factor Y, gamma, transcript variant X5
nuclear transcription factor Y subunit gamma isoform X1
nuclear transcription factor Y subunit gamma isoform X2
potassium voltage-gated channel subfamily KQT member 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily KQT member 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 4-like isoform X1
potassium voltage-gated channel subfamily KQT member 4-like isoform X2
tubulointerstitial nephritis antigen-like 1, transcript variant X2
tubulointerstitial nephritis antigen-like 1, transcript variant X1
tubulointerstitial nephritis antigen-like
28S ribosomal protein S15, mitochondrial
KH domain-containing, RNA-binding, signal transduction-associated protein 1-like
uncharacterized LOC122563765, transcript variant X2
uncharacterized LOC122563765, transcript variant X1
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
nuclear GTPase SLIP-GC-like, transcript variant X2
nuclear GTPase SLIP-GC-like, transcript variant X1
potassium voltage-gated channel subfamily S member 3-like, transcript variant X5
potassium voltage-gated channel subfamily S member 3-like, transcript variant X2
potassium voltage-gated channel subfamily S member 3-like, transcript variant X1
potassium voltage-gated channel subfamily S member 3-like, transcript variant X4
potassium voltage-gated channel subfamily S member 3-like, transcript variant X3
potassium voltage-gated channel subfamily S member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
interleukin-6 receptor subunit beta-like, transcript variant X2
interleukin-6 receptor subunit beta-like, transcript variant X4
interleukin-6 receptor subunit beta-like, transcript variant X3
interleukin-6 receptor subunit beta-like isoform X2
interleukin-6 receptor subunit beta-like, transcript variant X5
interleukin-6 receptor subunit beta-like, transcript variant X1
interleukin-6 receptor subunit beta-like isoform X1
interleukin-6 receptor subunit beta-like isoform X3
neuropeptides capa receptor-like, transcript variant X5
neuropeptides capa receptor-like, transcript variant X4
neuropeptides capa receptor-like, transcript variant X3
neuropeptides capa receptor-like, transcript variant X2
neuropeptides capa receptor-like, transcript variant X1
neuropeptides capa receptor-like, transcript variant X7
neuropeptides capa receptor-like, transcript variant X6
gastrula zinc finger protein XlCGF8.2DB-like, transcript variant X1
gastrula zinc finger protein XlCGF8.2DB-like, transcript variant X2
gastrula zinc finger protein XlCGF8.2DB-like
gastrula zinc finger protein XlCGF7.1-like, transcript variant X2
gastrula zinc finger protein XlCGF7.1-like, transcript variant X1
gastrula zinc finger protein XlCGF7.1-like
oocyte zinc finger protein XlCOF6.1-like
zinc finger protein 239-like, transcript variant X6
zinc finger protein 239-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X4
zinc finger protein 239-like, transcript variant X5
uncharacterized protein LOC122563774 isoform X1
uncharacterized protein LOC122563774 isoform X5
zinc finger protein 239-like, transcript variant X3
uncharacterized protein LOC122563774 isoform X3
zinc finger protein 239-like, transcript variant X2
uncharacterized protein LOC122563774 isoform X2
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
dihydrolipoyl dehydrogenase, mitochondrial